Multiple strategies are continuously being explored to expand the drug target repertoire in solid tumors. We devised a novel computational workflow for transcriptome-wide gene expression outlier analysis that allows the systematic identification of both overexpression and underexpression events in cancer cells. Here, it was applied to expression values obtained through RNA sequencing in 226 colorectal cancer (CRC) cell lines that were also characterized by whole-exome sequencing and microarray-based DNA methylation profiling. We found cell models displaying an abnormally high or low expression level for 3533 and 965 genes, respectively. Gene expression abnormalities that have been previously associated with clinically relevant features of CRC cell lines were confirmed. Moreover, by integrating multi-omics data, we identified both genetic and epigenetic alternations underlying outlier expression values. Importantly, our atlas of CRC gene expression outliers can guide the discovery of novel drug targets and biomarkers. As a proof of concept, we found that CRC cell lines lacking expression of the MTAP gene are sensitive to treatment with a PRMT5-MTA inhibitor (MRTX1719). Finally, other tumor types may also benefit from this approach.Multi-omics data were obtained for 226 CRC cell lines. Extreme positive and negative gene expression outliers were identified from RNA-seq data using a novel computational workflow. Gene expression abnormalities were subsequently associated with (epi)genetic alterations. Dataset exploration can guide the identification of drug targets and biomarkers through gene annotation, based on publicly available repositories, and drug screening assays. image

Transcriptome-wide gene expression outlier analysis pinpoints therapeutic vulnerabilities in colorectal cancer

Mariella, Elisa
First
;
Grasso, Gaia;Miotto, Martina;Buzo, Kristi;Reilly, Nicole Megan;Vitiello, Pietro Paolo;Crisafulli, Giovanni;Arena, Sabrina;Rospo, Giuseppe;Corti, Giorgio;Lorenzato, Annalisa;Barault, Ludovic;Gionfriddo, Giulia;Russo, Mariangela;Di Nicolantonio, Federica;Bardelli, Alberto
Last
2024-01-01

Abstract

Multiple strategies are continuously being explored to expand the drug target repertoire in solid tumors. We devised a novel computational workflow for transcriptome-wide gene expression outlier analysis that allows the systematic identification of both overexpression and underexpression events in cancer cells. Here, it was applied to expression values obtained through RNA sequencing in 226 colorectal cancer (CRC) cell lines that were also characterized by whole-exome sequencing and microarray-based DNA methylation profiling. We found cell models displaying an abnormally high or low expression level for 3533 and 965 genes, respectively. Gene expression abnormalities that have been previously associated with clinically relevant features of CRC cell lines were confirmed. Moreover, by integrating multi-omics data, we identified both genetic and epigenetic alternations underlying outlier expression values. Importantly, our atlas of CRC gene expression outliers can guide the discovery of novel drug targets and biomarkers. As a proof of concept, we found that CRC cell lines lacking expression of the MTAP gene are sensitive to treatment with a PRMT5-MTA inhibitor (MRTX1719). Finally, other tumor types may also benefit from this approach.Multi-omics data were obtained for 226 CRC cell lines. Extreme positive and negative gene expression outliers were identified from RNA-seq data using a novel computational workflow. Gene expression abnormalities were subsequently associated with (epi)genetic alterations. Dataset exploration can guide the identification of drug targets and biomarkers through gene annotation, based on publicly available repositories, and drug screening assays. image
2024
1
26
https://febs.onlinelibrary.wiley.com/doi/10.1002/1878-0261.13622
biomarkers; colorectal cancer; drug targets; gene expression outliers
Mariella, Elisa; Grasso, Gaia; Miotto, Martina; Buzo, Kristi; Reilly, Nicole Megan; Andrei, Pietro; Vitiello, Pietro Paolo; Crisafulli, Giovanni; Arena, Sabrina; Rospo, Giuseppe; Corti, Giorgio; Lorenzato, Annalisa; Cancelliere, Carlotta; Barault, Ludovic; Gionfriddo, Giulia; Linnebacher, Michael; Russo, Mariangela; Di Nicolantonio, Federica; Bardelli, Alberto
File in questo prodotto:
File Dimensione Formato  
2024-Transcriptome‐wide.pdf

Accesso aperto

Tipo di file: PDF EDITORIALE
Dimensione 5.19 MB
Formato Adobe PDF
5.19 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/1976853
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 1
  • ???jsp.display-item.citation.isi??? 0
social impact